| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.19 | 0.002 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.18 | 0.005 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.15 | 0.01 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.099 | 0.09 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.11 | 0.09 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.089 | 0.1 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.08 | 0.2 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.07 | 0.2 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.068 | 0.2 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.064 | 0.2 |